Skip to main content

Table 1 Patient characteristics at ICU admission according to disease group, and 28-day mortality

From: Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort

 

SARS-CoV-2 pneumonia

Influenza pneumonia

No viral infection

Alive (n = 402)

Dead (n = 166)

Alive (n = 350)

Dead (n = 132)

Alive (n = 344)

Dead (n = 182)

Age, yearsa

62 (53–70)

70 (62–78)

61 (52–70)

65 (54–72)

63 (52–72)

70 (60–76)

Men

281/402 (69.9)

126/166 (75.9)

219/350 (62.6)

79/131 (60.3)

239/342 (69.9)

114/182 (62.6)

Body mass index, kg/m2 b

28.7 (25.5–33.6)

29.1 (26.0–33.0)

27.5 (23.1–32.3)

27.6 (23.5–31.7)

26.3 (22.7–29.8)

26.9 (23.2–33.3)

Severity scores

      

SAPS IIc

38 (31–51)

48 (38–61)

48 (37–60)

58 (45–72)

51 (39–63)

63 (51–73)

SOFA scored

6 (3–8)

7 (4–10)

8 (5–10)

10 (7–13)

8 (5–11)

9 (7–12)

Comorbidity scores

      

MacCabe classification

      

 Non-fatal

347/382 (90.8)

128/161 (79.5)

249/332 (75.0)

75/124 (60.5)

216/318 (67.9)

99/171 (57.9)

 Fatal < 5 years

33/382 (8.6)

29/161 (18.0)

78/332 (23.5)

36/124 (29.0)

90/318 (28.3)

47/171 (27.5)

 Fatal < 1 year

2/382 (0.5)

4/161 (2.5)

5/332 (1.5)

13/124 (10.5)

12/318 (3.8)

25/171 (14.6)

Charlson Comorbidity Indexe

2 (1–3)

4 (2–5)

3 (2–5)

4 (2–6)

3 (2–5)

5 (3–6)

Chronic diseases

      

 Diabetes mellitus

113/399 (28.3)

55/166 (33.1)

72/344 (20.9)

32/130 (24.6)

82/338 (24.3)

50/181 (27.6)

 Chronic renal failure

11/395 (2.8)

22/164 (13.4)

25/346 (7.2)

14/129 (10.9)

22/339 (6.5)

23/182 (12.6)

 Cardiovascular disease

59/396 (14.9)

44/164 (26.8)

80/346 (23.1)

37/130 (28.5)

72/337 (21.4)

62/181 (34.3)

 Chronic heart failure

12/394 (3.0)

9/164 (5.5)

19/345 (5.5)

18/130 (13.8)

24/336 (7.1)

26/182 (14.3)

 COPD

26/396 (6.6)

11/164 (6.7)

96/344 (27.9)

33/131 (25.2)

63/339 (18.6)

35/182 (19.2)

 Chronic respiratory failure

12/394 (3.0)

8/164 (4.9)

56/344 (16.3)

11/131 (8.4)

28/336 (8.3)

21/182 (11.5)

 Cirrhosis

6/395 (1.5)

2/164 (1.2)

10/345 (2.9)

6/130 (4.6)

18/335 (5.4)

18/181 (9.9)

 Immunosuppression

29/395 (7.3)

23/164 (14.0)

61/348 (17.5)

46/131 (35.1)

71/340 (20.9)

46/180 (25.6)

 Active smoking

20/396 (5.1)

9/164 (5.5)

122/346 (35.3)

27/130 (20.8)

102/337 (30.3)

35 /182 (19.2)

 Alcohol abuse

29/394 (7.4)

5/164 (3.0)

65/345 (18.8)

20/130 (15.4)

89/337 (26.4)

43/182 (23.6)

Location before ICU admission

      

 Home

187/402 (46.5)

84/166 (50.6)

212/349 (60.7)

63/132 (47.7)

180/344 (52.3)

85/182 (46.7)

 Hospital ward

154/402 (38.3)

61/166 (36.7)

104/349 (29.8)

53/132 (40.2)

147/344 (42.7)

83/182 (45.6)

 Another ICU

61/402 (15.2)

21/166 (12.7)

33/349 (9.5)

16/132 (12.1)

17/344 (4.9)

14/182 (7.7)

Admission category

      

 Medical

401/402 (99.8)

166/166 (100.0)

348/350 (99.4)

132/132 (100.0)

302/344 (87.8)

165/182 (90.7)

 Surgical

0/402 (0.0)

0/166 (0.0)

0/350 (0.0)

0/132 (0.0)

11/344 (3.2)

6/182 (3.3)

 Trauma

1/402 (0.2)

0/166 (0.0)

2/350 (0.6)

0/132 (0.0)

31/344 (9.0)

11/182 (6.0)

Recent hospitalization (< 3 months)

26/401 (6.5)

18/165 (10.9)

41/348 (11.8)

31/131 (23.7)

90/342 (26.3)

58/182 (31.9)

Recent antibiotic treatment (< 3 months)

50/402 (12.4)

24/165 (14.5)

56/347 (16.1)

39/130 (30.0)

56/342 (16.4)

47/182 (25.8)

Causes for ICU admission

      

 Shock

58/394 (14.7)

44/163 (27.0)

144/343 (42.0)

66/127 (52.0)

147/336 (43.8)

97/179 (54.2)

 Acute respiratory failure

371/401 (92.5)

150/166 (90.4)

316/349 (90.5)

117/131 (89.3)

196/334 (58.7)

83/179 (46.4)

 ARDS

271/398 (68.1)

115/165 (69.7)

157/342 (45.9)

63/127 (49.6)

44/330 (13.3)

28/179 (15.6)

 Neurological failure

13/385 (3.4)

13/163 (8.0)

51/339 (15.0)

18/126 (14.3)

128/331 (38.7)

63/178 (35.4)

 Cardiac arrest

1/384 (0.3)

2/163 (1.2)

14/338 (4.1)

11/127 (8.7)

40/329 (12.2)

44/179 (24.6)

 Acute kidney injury

48/385 (12.5)

48/163 (29.4)

84/337 (24.9)

49/124 (39.5)

87/327 (26.6)

49/178 (27.5)

  1. Values are as no./No. (%) or median (interquartile range)
  2. McCabe classification of comorbidities and likelihood of survival, likely to survive > 5 years, 1–5 years, < 1 year; Chronic renal failure, KDOQI CKD classification stage 4 or 5 (creatinine clearance < 30 ml/mn); Chronic heart failure, NYHA class III or IV; Heart disease, ischemic heart disease or atrial fibrillation; Cirrhosis, Child–Pugh score B or C; Immunosuppression if haematological malignancy, allogenic stem cell transplant, organ transplant, HIV or immunosuppressive drugs; More than one cause for ICU admission is possible
  3. a1 missing value in influenza group; b 160 missing values (SARS-CoV-2, n = 32; influenza, n = 68; controls, n = 60); c 87 missing values (SARS-CoV-2, n = 43; influenza, n = 21; controls, n = 21); d 27 missing values (SARS-CoV-2, n = 21; influenza, n = 4; controls, n = 2); e 50 missing values (SARS-CoV-2, n = 19; influenza, n = 11; controls, n = 20)